The MSc in Clinical and Therapeutic Neuroscience was first launched in October 2019 and is run jointly with the Departments of Psychiatry and Nuffield Department of Clinical Neurosciences, together with essential contributions from allied departments and institutions in Oxford.
Overall, the academic standard of the cohort was extremely high, and after much deliberation, the Exam Board judged that the following candidates deserved special recognition. All prize winners have received an Amazon gift voucher. Six students from this class are staying in Oxford either to study for a DPhil, or take up a Research Assistant post. We wish the whole class the very best of luck with their future endeavours.
Jonathan Cattrall (Foundation Doctor)
- Most Improved Student Prize, for demonstrating exceptional diligence and academic progress over the year.
- Dissertation Prize for: 'Are clinicians qualitative Bayesian reasoners when using clinical decision support tools?'
- Poster Prize (joint winner), for excellent performance in the poster viva voce examination where he presented: 'Investigating heart rate variability as a marker of disease severity and autonomic nervous system dysfunction in patients with tetanus'
Kristina Funk (Biomedical Scientist and Neuroscientist)
- Poster Prize (joint winner), for excellent performance in the poster viva voce examination where she presented: 'Using deep learning to identify metabolite biomarkers of Alzheimer's disease'
Muyang Lin (Biomedical Scientist)
- Highest Achievement Prize for attaining the top final mark, and consistently high marks throughout the year.
- Essay Prize for attaining a Distinction level for all four summative essays.
- Essay Prize for: 'The potentials and challenges of using neuromelanin sensitive magnetic resonance imaging as a diagnostic and monitoring biomarker for Parkinson's Disease'
Georgina Miller (Neuroscientist)
- Poster Prize (joint winner), for excellent performance in the poster viva voce examination where she presented: 'Induced pluripotent stem cell-derived astrocytes reflect in vivo measures of Alzheimer's disease vulnerability'